Metagenomic next-generation sequencing as an emerging modality for the diagnosis of infectious diseases

FHS
August 1, 2023
10:18 am

Study examined the role of plasma metagenomic next-generation sequencing.

Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity – Biotech Investments

Biophytis / Key word(s): Miscellaneous/Miscellaneous Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity 11-Jul-2024 / 08:13 CET/CEST

July 12, 2024

Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets – Biotech Investments

EQS-News: Cantourage Group SE / Key word(s): Development of Sales/Monthly Figures New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October

November 21, 2024

Anti-PD-1 Alone Produces Durable Responses in Relapsed/Refractory PMBCL

Single-agent pembrolizumab (Keytruda) produced durable responses and encouraging survival in patients with relapsed/refractory (R/R) primary mediastinal B-cell lymphoma (PMBCL), according to long-term follow-up of a

July 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.